IDiyas

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Helen Louise Francis-Lang

USPTO Granted Patents = 15 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 89(Granted Patents)


Company Filing History:

goldMedal14 out of 173 
 
Exelixis, Inc.
 patents
silverMedal1 out of 12 
 
Nodality, Inc.
 patents

Years Active: 2003-2015

Loading Chart...
15 patents (USPTO):Explore Patents
1. 9182385 - Methods for diagnosis, prognosis and methods of treatment (2015-11-10),
2. 8771942 - SCDs as modifiers of the p53 pathway and methods of use (2014-07-08),
3. 8632962 - PLKS as modifiers of the beta catenin pathway and methods of use (2014-01-21),
4. 8426147 - RORS as modifiers of the p21 pathway and methods of use (2013-04-23),
5. 8268548 - MAP3Ks as modifiers of the p53 pathway and methods of use (2012-09-18),
6. 8153384 - Marks as modifiers of the p53 pathway and methods of use (2012-04-10),
7. 7993829 - HPRP4s modifiers of the p53 pathway and methods of use (2011-08-09),
8. 7943302 - C20ORF23 as modifier of the IGFR pathway and methods of use (2011-05-17),
9. 7888048 - P4HAS as modifiers of the IGFR pathway and methods of use (2011-02-15),
10. 7888047 - PDEs as modifiers of the IGFR pathways and methods of use (2011-02-15),
11. 7785805 - MAN2As as modifiers of the IGFR pathway and methods of use (2010-08-31),
12. 7049088 - PRMTs as modifiers of the p53 pathway and methods of use (2006-05-23),
13. 6972179 - RRP sequences and knockout mice and uses thereof (2005-12-06),
14. 6703491 - Drosophila sequences (2004-03-09),
15. 6511824 - Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use (2003-01-28),

Title: The Innovative Journey of Helen Louise Francis-Lang

Introduction: Helen Louise Francis-Lang is a prominent inventor based in San Francisco, CA, who has made significant contributions to the field of medical diagnostics and treatment. With a remarkable portfolio of 15 patents, her work focuses on advanced methods for diagnosing and treating various medical conditions, showcasing her dedication to enhancing healthcare through innovation.

Latest Patents: Among her latest patents, the invention titled "Methods for Diagnosis, Prognosis, and Methods of Treatment" stands out. This invention is directed towards methods and compositions aimed at diagnosing and monitoring conditions such as Chronic Lymphocytic Leukemia. It utilizes the physiological status of cells from clinical samples to aid in patient selection for therapy and optimize therapeutic regimens. Another significant contribution is her patent regarding "SCDs as Modifiers of the p53 Pathway and Methods of Use," where she identifies human SCD genes as modulators of the p53 pathway, targeting disorders associated with defective p53 function.

Career Highlights: Helen's career has been distinguished by her work in well-respected companies, including Exelixis, Inc. and Nodality, Inc. Her contributions in these organizations have not only advanced technical knowledge but also fostered innovations that have the potential to transform treatment protocols in clinical settings.

Collaborations: Throughout her career, Helen has collaborated with notable professionals, including Lori Friedman and Gregory D Plowman. These partnerships have significantly contributed to her innovative endeavors, enriching her research and expanding the impact of her inventions.

Conclusion: Helen Louise Francis-Lang exemplifies the spirit of innovation in the medical field. Her extensive patent portfolio and collaborative efforts reflect her commitment to improving patient outcomes through advanced diagnostic and therapeutic methods. As the landscape of medical technology continues to evolve, her contributions are poised to leave a lasting legacy in healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…